Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility.

Schizophrenia research 20120501

Social cognition and visual perception in schizophrenia inpatients treated with first-and second-generation antipsychotic drugs.

Clinical schizophrenia & related psychoses 20120401

Prevalence of neuroleptic-induced restless legs syndrome in patients taking neuroleptic drugs.

Journal of the neurological sciences 20120315

Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs.

Medical science monitor : international medical journal of experimental and clinical research 20120101

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.

Clinical schizophrenia & related psychoses 20111001

Alternative methods for testing treatment effects on the basis of multiple outcomes: simulation and case study.

Statistics in medicine 20110720

Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.

Journal of medicinal chemistry 20110714

Periodic catatonia.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20110501

Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.

The Journal of clinical psychiatry 20110301

Post-operative nausea and vomiting prevention with perphenazine: long overdue.

European journal of anaesthesiology 20110201

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

Molecular psychiatry 20110101

Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia.

The Journal of clinical psychiatry 20110101

Fast-dissolving sublingual solid dispersion and cyclodextrin complex increase the absorption of perphenazine in rabbits.

The Journal of pharmacy and pharmacology 20110101

Electroconvulsive therapy for the treatment of refractory mania.

Journal of psychiatric practice 20110101

Investigation of neuropsychopharmacological effects of a polyherbal formulation on the learning and memory process in rats.

Journal of young pharmacists : JYP 20110101

Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses.

Neuro endocrinology letters 20110101

Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings.

Frontiers in psychiatry 20110101

Efficacy of perphenazine to prevent postoperative nausea and vomiting: a quantitative systematic review.

European journal of anaesthesiology 20101201

Identification of human Ether-à-go-go related gene modulators by three screening platforms in an academic drug-discovery setting.

Assay and drug development technologies 20101201

Schizophrenia: The drug deadlock.

Nature 20101111

Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Bioorganic & medicinal chemistry letters 20101101

Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation.

Drug development and industrial pharmacy 20100501

The number needed to treat for all-cause medication discontinuation in the treatment of schizophrenia: consistency across world geographies and study designs.

Pharmacopsychiatry 20100501

Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions.

Toxicology 20100411

Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study.

Schizophrenia research 20100301

A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle.

Proceedings of the National Academy of Sciences of the United States of America 20100223

Effect of perphenazine enanthate on open-field test behaviour and stress-induced hyperthermia in domestic sheep.

Pharmacology, biochemistry, and behavior 20100101

BL-1020, an oral antipsychotic agent that reduces dopamine activity and enhances GABAA activity, for the treatment of schizophrenia.

Current opinion in investigational drugs (London, England : 2000) 20100101

An open-label tolerability study of BL-1020 antipsychotic: a novel gamma aminobutyric acid ester of perphenazine.

Clinical neuropharmacology 20100101

Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats.

Pharmacology, biochemistry, and behavior 20091201

BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humans.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20091201

The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial.

Schizophrenia research 20091101

Clinical trials design lessons from the CATIE study.

The American journal of psychiatry 20091101

Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

Nature chemical biology 20091001

A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.

Bioorganic & medicinal chemistry letters 20090901

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

Lancet (London, England) 20090822

Effect of antipsychotic drug perphenazine on fast sodium current and transient outward potassium current in rat ventricular myocytes.

Naunyn-Schmiedeberg's archives of pharmacology 20090801

Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.

The Journal of clinical psychiatry 20090421

Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.

Bioorganic & medicinal chemistry 20090315

Stability of medication in early psychosis: a comparison between second-generation and low-dose first-generation antipsychotics.

Early intervention in psychiatry 20090201

BL-1020: a novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090101

Results of phase 3 of the CATIE schizophrenia trial.

Schizophrenia research 20090101

Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition.

Archives of toxicology 20081201

Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.

Bipolar disorders 20081201

Hiccups and dopamine.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081115

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

Journal of medicinal chemistry 20081113

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.

Schizophrenia research 20080801

Clinical experiences and clinical trials.

CNS spectrums 20080601

A mutual prodrug ester of GABA and perphenazine exhibits antischizophrenic efficacy with diminished extrapyramidal effects.

Journal of medicinal chemistry 20080508

Acute dystonia induced by the combination of midodrine and perphenazine.

Journal of neurology 20080501

Did CATIE influence antipsychotic use?

Psychiatric services (Washington, D.C.) 20080501

Introduction to the CATIE special section.

Psychiatric services (Washington, D.C.) 20080501

What CATIE found: results from the schizophrenia trial.

Psychiatric services (Washington, D.C.) 20080501

Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia.

The journal of behavioral health services & research 20080401

The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.

Schizophrenia research 20080301

Metoclopramide, an increasingly recognized cause of tardive dyskinesia.

Journal of clinical pharmacology 20080301

A somatic type delusional disorder secondary to peripheral neuropathy: a case report.

Psychiatria Danubina 20080301

Treatment of idiopathic recurrent priapism with fluoxetine and low dose Perphenazine.

JPMA. The Journal of the Pakistan Medical Association 20080301

Discontinuation of lithium augmentation in geriatric patients with unipolar depression: a systematic review.

Canadian journal of psychiatry. Revue canadienne de psychiatrie 20080201

Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.

Biological psychiatry 20080101

Clinical characteristics and psychopathological profile of patients with vulvodynia: an observational and descriptive study.

Dermatology (Basel, Switzerland) 20080101

[Consumption of inappropriate psychotropic drugs in residential homes for the elderly: comparative study between 2001 and 2006].

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20080101

Clinical implications of the CATIE schizophrenia trials: day-to-day management lessons for Australasian psychiatrists.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 20071201

Aripiprazole and perphenazine: no difference.

The Journal of clinical psychiatry 20071101

CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine.

Pharmacogenetics and genomics 20071101

Neuroleptic malignant syndrome resulting from a complex drug-drug interaction: 'I don't see 'em!'.

Journal of psychiatric practice 20070901

Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.

Schizophrenia research 20070701

HPLC quantification of perphenazine in sheep plasma: application to a pharmacokinetic study.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070701

Long-acting neuroleptics used in wildlife management do not impair thermoregulation or physical activity in goats (Capra hircus).

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 20070601

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

Archives of general psychiatry 20070601

CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6-serotonin-dopamine crosstalk revisited.

Pharmacogenetics and genomics 20070501

Permanent lithium-induced cerebellar toxicity: three cases and review of literature.

Movement disorders : official journal of the Movement Disorder Society 20070315

Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.

Psychopharmacology 20070301

Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.

The American journal of psychiatry 20070301

Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.

The American journal of psychiatry 20070301

Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.

The Journal of clinical psychiatry 20070201

[Antipsychotics--clever choices].

Lakartidningen 20070201

Relative risk of glucose elevation during antipsychotic exposure in a Veterans Administration population.

International clinical psychopharmacology 20070101

Nerve growth factor mRNA expression in the regenerating antler tip of red deer (Cervus elaphus).

PloS one 20070101

Routine multimodal antiemesis including low-dose perphenazine in an ambulatory surgery unit of a university hospital: a 10-year history. Supplement to: Eliminating postoperative nausea and vomiting in outpatient surgery with multimodal strategies including low doses of nonsedating, off-patent antiemetics: is 'zero tolerance' achievable?

TheScientificWorldJournal 20070101

[Neuroleptic treatment and neurological soft signs in schizophrenic patients].

Therapie 20070101

Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.

The American journal of psychiatry 20061201

Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia.

International clinical psychopharmacology 20060901

[Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].

No to shinkei = Brain and nerve 20060601

Selecting antipsychotics in schizophrenia: lessons from CATIE.

Journal of psychopharmacology (Oxford, England) 20060501

Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Antipsychotic drugs and schizophrenia.

The New England journal of medicine 20060119

Antipsychotic drugs and schizophrenia.

The New England journal of medicine 20060119

Interpreting the results of the CATIE study.

Psychiatric services (Washington, D.C.) 20060101

Interpreting the results of the CATIE study.

Psychiatric services (Washington, D.C.) 20060101

Interpreting the results of the CATIE study.

Psychiatric services (Washington, D.C.) 20060101

In vitro phototoxicity of phenothiazines: involvement of stable UVA photolysis products formed in aqueous medium.

Chemical research in toxicology 20060101

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.

BMC psychiatry 20060101

The CATIE schizophrenia effectiveness trial.

Schizophrenia research 20051201

Stability and characterization of perphenazine aerosols generated using the capillary aerosol generator.

International journal of pharmaceutics 20051013

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

The New England journal of medicine 20050922

PASS assisted search and evaluation of some azetidin-2-ones as C.N.S. active agents.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20050803

Depot perphenazine decanoate and enanthate for schizophrenia.

The Cochrane database of systematic reviews 20050720

Prediction of genotoxicity of chemical compounds by statistical learning methods.

Chemical research in toxicology 20050601

[Differentiation-inducing effects of perphenazine on K562 leukemia cells].

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20050601

Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.

Psychopharmacology 20050501

Mitochondria and plasma membrane as targets of UVA-induced toxicity of neuroleptic drugs fluphenazine, perphenazine and thioridazine.

The international journal of biochemistry & cell biology 20050401

Effect of anionic additive type on ion pair formation constants of basic pharmaceuticals.

Journal of chromatography. A 20050401

Kinetic spectrophotometric method for determination of perphenazine based on monitoring the oxidation intermediate by applying a stopped-flow technique.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20050301

Application of two chemometric methods for the determination of imipramine, amitriptyline and perphenazine in content uniformity and drug dissolution studies.

Journal of pharmaceutical and biomedical analysis 20050223

Perphenazine for schizophrenia.

The Cochrane database of systematic reviews 20050125

Antiemetics in outpatient regional anesthesia for invasive orthopedic surgery.

International anesthesiology clinics 20050101

Switching patients from olanzapine or risperidone to a combination treatment using perphenazine plus buspirone: evaluation of antipsychotic efficacy and side-effects, including extrapyramidal effects and weight loss.

Nordic journal of psychiatry 20050101

Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.

In vivo (Athens, Greece) 20050101

Comparison of the effect of the R2 phenothiazine ring substituent on fluphenazine and perphenazine interactions with cyclodextrins.

Acta poloniae pharmaceutica 20050101

A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration.

Psychopharmacology 20040901

Nausea and vomiting after outpatient ACL reconstruction with regional anesthesia: are lumbar plexus blocks a risk factor?

Journal of clinical anesthesia 20040601

Photo-distributed neutrophilic drug eruption and adult respiratory distress syndrome associated with antidepressant therapy.

Journal of cutaneous pathology 20040201

An unexpected increase of troponin I after perphenazine depot injection.

The Annals of pharmacotherapy 20040201

Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients.

The American journal of psychiatry 20040101

Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.

BMC psychiatry 20040101

Induction of the rabbit syndrome following coadministration of paroxetine, perphenazine, and amitriptyline.

Clinical neuropharmacology 20040101

Schizophrenia, VI: Treatments.

The American journal of psychiatry 20031001

Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).

Journal of medicinal chemistry 20030703

Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition.

Pharmacology 20030601

Photosensitization of DNA strand breaks by three phenothiazine derivatives.

Chemical research in toxicology 20030501

How long should patients with psychotic depression stay on the antipsychotic medication?

The Journal of clinical psychiatry 20030401

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030301

Phenothiazine radicals inactivate Trypanosoma cruzi dihydrolipoamide dehydrogenase: enzyme protection by radical scavengers.

Free radical research 20030301

New benzo[h][1,6]naphthyridine and azepino[3,2-c]quinoline derivatives as selective antagonists of 5-HT4 receptors: binding profile and pharmacological characterization.

Journal of medicinal chemistry 20030102

Drug-induced toxic myocarditis.

Texas Heart Institute journal 20030101

[Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial].

Psychiatria polska 20030101

Disturbed glucose metabolism among patients taking olanzapine and typical antipsychotics.

Psychopharmacology bulletin 20030101

Simultaneous dissolution profiles of two drugs, sulfadiazine-trimethoprim and amitriptyline-perphenazine, in solid oral dosage forms by a FIA manifold provided with a single spectrophotometric detector.

Journal of pharmaceutical and biomedical analysis 20021015

Hydrophobia as a rare presentation of Cotard's syndrome: a case report.

Acta psychiatrica Scandinavica 20020801

Role of adenosine in drug-induced catatonia in mice.

Indian journal of experimental biology 20020801

[Simple preparation and evaluations of amide-octyl-bonded phase].

Se pu = Chinese journal of chromatography 20020501

Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

The Journal of biological chemistry 20020419

Quantification of perphenazine in eurasian otter (Lutra lutra lutra) urine samples by gas chromatography-mass spectrometry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020325

Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.

The American journal of psychiatry 20020301

Extractive-spectrophotometric determination of some phenothiazines with dipicrylamine and picric acid.

Journal of pharmaceutical and biomedical analysis 20020101

Simultaneous determination of promethazine, chlorpromazine, and perphenazine by multivariate calibration methods and derivative spectrophotometry.

Journal of AOAC International 20020101

Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.

Proceedings of the Western Pharmacology Society 20020101

Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms.

Cellular and molecular neurobiology 20011201

Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland.

Molecular endocrinology (Baltimore, Md.) 20011101

Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations.

The Journal of nervous and mental disease 20011101

Agranulocytosis and neutropenia with typical and atypical neuroleptics.

The American journal of psychiatry 20011001

Effects of ADP on different inhibitory properties of brain glutamate dehydrogenase isoproteins by perphenazine.

Biochimie 20010901

Evaluation of long-term sedation in cheetah (Acinonyx jubatus) with perphenazine enanthate and zuclopenthixol acetate.

Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 20010901

Antipsychotic radioreceptor assay: a modification identifying selective receptor effects.

Therapeutic drug monitoring 20010801

Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs.

European journal of clinical pharmacology 20010701

Noninvasive monitoring of adrenocortical activity in roe deer (Capreolus capreolus) by measurement of fecal cortisol metabolites.

General and comparative endocrinology 20010701

Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7,263 treatment courses.

Journal of clinical psychopharmacology 20010401

Therapeutic drug monitoring of haloperidol, perphenazine, and zuclopenthixol in serum by a fully automated sequential solid phase extraction followed by high-performance liquid chromatography.

Therapeutic drug monitoring 20010401

Fluvoxamine for psychosis in Alzheimer's disease.

The Journal of nervous and mental disease 20010201

The changes of biological markers and treatment efficacy in schizophrenia.

Progress in neuro-psychopharmacology & biological psychiatry 20010201

Exacerbation of psychosis by phenylpropanolamine.

The American journal of psychiatry 20000601

[Diabetes mellitus after treatment with clozapine].

Nederlands tijdschrift voor geneeskunde 20000226

Perphenazine-induced hiccups.

Pharmacopsychiatry 19990301

Acquired aplastic anemia secondary to perphenazine.

The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 19990101

Olanzapine use in women with antipsychotic-induced hyperprolactinemia.

The American journal of psychiatry 19981001

Association of plasma homovanillic acid with behavioral symptoms in patients diagnosed with dementia: a preliminary report.

Biological psychiatry 19971201

Induction of mania by risperidone resistant to mood stabilizers.

Journal of clinical psychopharmacology 19970201

Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.

Psychopharmacology 19960301

BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats.

Journal of neural transmission (Vienna, Austria : 1996) 19960101

The efficacy of prophylactic ondansetron, droperidol, perphenazine, and metoclopramide in the prevention of nausea and vomiting after major gynecologic surgery.

Anesthesia and analgesia 19950701

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

The Journal of pharmacology and experimental therapeutics 19940301

Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations.

Acta psychiatrica Scandinavica 19931201

D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.

Psychopharmacology 19920101

Extrapyramidal symptoms and their relationship to clinical efficacy under perphenazine treatment. A controlled prospective handwriting-test study in 22 acutely ill schizophrenic patients.

Pharmacopsychiatry 19910701

The relationship between blood perphenazine levels, early resolution of psychotic symptoms, and side effects.

The Journal of clinical psychiatry 19900801

Neurologic approach to drug-induced movement disorders: a study of 125 patients.

Southern medical journal 19900501

Zuclopenthixol and perphenazine in patients with acute psychotic states. A double-blind multicentre study.

Pharmacopsychiatry 19870701

Neuroleptic malignant syndrome during perphenazine treatment.

Pharmacology & toxicology 19870301

L-tryptophan in drug-induced movement disorders with insomnia.

The New England journal of medicine 19860508

Tourette-like syndrome following low dose short-term neuroleptic treatment.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 19860501

A case of progressive hemichorea responsive to high-dose reserpine.

The Journal of clinical psychiatry 19860301

Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.

Psychopharmacology 19860101

GABAergic, dopaminergic and cholinergic interactions in perphenazine-induced catatonia in rats.

Archives internationales de pharmacodynamie et de therapie 19851201

Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.

Naunyn-Schmiedeberg's archives of pharmacology 19850401

Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes.

Proceedings of the National Academy of Sciences of the United States of America 19840901

Unique sensitivity of Hb Zürich to oxidative injury by phenazopyridine: reversal of the effects by elevating carboxyhemoglobin levels in vivo and in vitro.

American journal of hematology 19830601

Cerebellar syndrome following neuroleptic induced heat stroke.

Journal of neurology, neurosurgery, and psychiatry 19830201

Capgras phenomenon, delirium, and transient hepatic dysfunction.

Hospital & community psychiatry 19820501

Dose-response relationships of perphenazine in the treatment of acute psychoses.

Psychopharmacology 19820101

Prolactin and the small intestine. Effect of hyperprolactinaemia on mucosal structure in the rat.

Gut 19810701

Actions of clonidine on convulsions and behaviour.

Archives internationales de pharmacodynamie et de therapie 19810701

Tricyclic antidepressants and alcoholic blackouts.

The Journal of nervous and mental disease 19810601

Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects.

Psychopharmacology 19810101

Pituitary sensitivity to LHRH in hyperprolactinemia induced by perphenazine and renal pituitary transplants in female rats.

Biology of reproduction 19800401

Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment.

The British journal of psychiatry : the journal of mental science 19791101

Electrophysiologic studies of perphenazine and protriptyline in a patient with psychotropic drug-induced ventricular fibrillation.

The American journal of medicine 19790801

Seven cases of somnambulism induced by drugs.

The American journal of psychiatry 19790701

Metoclopramide and dystonic reactions in Sardinians.

Lancet (London, England) 19790623

Toxic psychosis with cimetidine.

The American journal of psychiatry 19790501

Death attributed to ventricular arrhythmia induced by thioridazine in combination with a single Contac C capsule.

Canadian Medical Association journal 19781007

[Acute dystonia in children. 2 cases caused by perphenazine (Trilafon)].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 19780310

Effects and side-effects of bromperidol in comparison with other antipsychotic drugs.

Acta psychiatrica Belgica 19780101

Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms.

Lancet (London, England) 19770312

Asymptomatic idiopathic syndrome of prolonged Q-T interval in a 45-year-old woman. Ventricular tachyarrhythmias precipitated by hypokalemia and therapy with amitriptyline and prephenazine.

Chest 19770201

Tetany, tetanus or drug reaction? A case report.

British journal of anaesthesia 19760701

High-dosage and versatile drug therapy with treatment-resistant psychotic patients.

Hospital & community psychiatry 19760101

[Psychometric effects of perphenacine below the 'neuroleptic threshold' (author's transl)].

Pharmakopsychiatrie, Neuro-Psychopharmakologie 19751201

Letter: Side-effects of perphenazine.

Lancet (London, England) 19750621

Drug-induced dystonia.

The American journal of psychiatry 19750501

Tardive dyskinesia treated with pimozide.

Journal of the neurological sciences 19750401

Tissue metabolites of trifluorperazine, fluphenazine, prochlorperazine, and perphenazine. Kinetics in chronic treatment.

Drug metabolism and disposition: the biological fate of chemicals 19750101

Reversal of delirium induced by tricyclic antidepressant drugs with physostigmine.

The American journal of psychiatry 19741101

Piritramide and pethidine. A comparison of their use as supplements in general anaesthesia.

Anaesthesia 19741101

The mechanism of the potentiating effect of antidepressant drugs on the protective influenc oe of diphenhydramine in experimental catatonia. The role of histamine.

Pharmacology 19740101

Idiosyncratic responses to phenothiazines.

British medical journal 19720122

A review of clinical studies with combinations of fluphenazine and nortriptyline.

Current medical research and opinion 19720101

Increased sensitivity to neuroleptics in rats with lesions of the central nervous system.

Psychopharmacologia 19720101

Sudden death in phenothiazine therapy. (A clinicopathologic study of 12 cases).

The Psychiatric quarterly 19700101

Iatrogenic epilepsy due to antidepressant drugs.

British medical journal 19691011

Dystonic reaction to perphenazine.

Lancet (London, England) 19690809

Perphenazine dystonia presenting as recurrent dislocation of the jaw.

The Journal of laryngology and otology 19690101

Phenothiazines and diabetes in hospitalized women.

The American journal of psychiatry 19680101

Oculogyric crises due to phenothiazines.

British medical journal 19670722

Side-effects of phenothiazines.

British medical journal 19670401

Phenothiazines in early labour.

British medical journal 19670211

The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.

The Psychiatric quarterly 19670101

Specific therapeutic actions of acetophenazine, perphenazine, and benzquinamide in newly admitted schizophrenic patients.

Clinical pharmacology and therapeutics 19670101

Drug-induced extrapyramidal symptoms: their incidence and treatment.

The American journal of psychiatry 19670101

A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.

The British journal of psychiatry : the journal of mental science 19660601

The effect of SA 97, perphenazine, and hydroxyzine on epinephrine-induced cardiac arrhythmias during methoxyflurane anaesthesia in dogs.

Canadian Anaesthetists' Society journal 19620101

The effect of perphenazine on epinephrine-induced cardiac arrhythmias in dogs. II. Anaesthesia with cyclopropane, chloroform, and trichlorethylene.

Canadian Anaesthetists' Society journal 19590701